1.63
1.24%
0.02
After Hours:
1.63
Intelligent Bio Solutions Inc stock is traded at $1.63, with a volume of 107.36K.
It is up +1.24% in the last 24 hours and up +4.49% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
See More
Previous Close:
$1.61
Open:
$1.66
24h Volume:
107.36K
Relative Volume:
0.06
Market Cap:
$7.06M
Revenue:
$2.46M
Net Income/Loss:
$-13.40M
P/E Ratio:
-0.1682
EPS:
-9.69
Net Cash Flow:
$-7.34M
1W Performance:
+16.43%
1M Performance:
+4.49%
6M Performance:
-29.44%
1Y Performance:
-55.73%
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-233-6971
Address
135 W 41ST ST,, NEW YORK
Compare INBS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.63 | 7.06M | 2.46M | -13.40M | -7.34M | -9.69 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions completes fingerprint drug screening system study - Yahoo! Voices
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Inc. Achieves 94.1% Accuracy in Method Comparison Study, Following Positive Pk Study Results - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com UK
INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com
Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks
INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Intelligent Bio : INBS PK Study Results Video - Marketscreener.com
INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com
INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - GlobeNewswire
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach - Yahoo Finance
Intelligent Bio Solutions Inc (INBS-Q) QuotePress Release - The Globe and Mail
Intelligent Bio Solutions partners with B2i Digital for marketing push - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.58% - MSN
Intelligent Bio Solutions Partners with B2i Digital to Enhance Investor Engagement - EIN News
Intelligent Bio Solutions partners with B2i Digital for marketing push By Investing.com - Investing.com UK
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - The Manila Times
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - The Manila Times
Intelligent Bio Solutions reports revenue growth and strategic expansion By Investing.com - Investing.com South Africa
Intelligent Bio Solutions reports revenue growth and strategic expansion - Investing.com
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - The Manila Times
TeraWulf Schedules Conference Call for Third Quarter 2024 Financial Results - The Manila Times
Intelligent Bio Solutions Inc. Provides Revenue Guidance for the First Quarter Ended September 30, 2024 - Marketscreener.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):